Alto Neuroscience (ANRO) Non Operating Income (2023 - 2026)

Alto Neuroscience has disclosed Non Operating Income across 4 years of filings, most recently posting $901000.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at $901000.0, up 77.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 47.6% YoY), and the FY2025 annual result was $3.1 million, down 56.46% from the prior year.
• Non Operating Income came in at $901000.0 for Q1 2026 at Alto Neuroscience, up from $873000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.3 million in Q2 2024 to a low of -$83000.0 in Q1 2023.
• The 4-year median for Non Operating Income is $873000.0 (2025), against an average of $977692.3.
• Across the five-year window, Non Operating Income soared 1267.47% in 2024 and sank 63.39% in 2025, its largest moves.
• Alto Neuroscience's Non Operating Income stood at $548000.0 in 2023, then surged by 227.74% to $1.8 million in 2024, then plunged by 51.39% to $873000.0 in 2025, then gained by 3.21% to $901000.0 in 2026.
• The last three Non Operating Income figures came in at $901000.0 (Q1 2026), $873000.0 (Q4 2025), and $770000.0 (Q3 2025), per Business Quant data.